Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta

Amyloid protein aggregates are associated with dozens of devastating diseases including Alzheimer’s, Parkinson’s, ALS, and diabetes type 2. While structure-based discovery of compounds has been effective in combating numerous infectious and metabolic diseases, ignorance of amyloid structure has hind...

Full description

Bibliographic Details
Main Authors: Lin Jiang, Cong Liu, David Leibly, Meytal Landau, Minglei Zhao, Michael P Hughes, David S Eisenberg
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2013-07-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/00857
_version_ 1811201244276981760
author Lin Jiang
Cong Liu
David Leibly
Meytal Landau
Minglei Zhao
Michael P Hughes
David S Eisenberg
author_facet Lin Jiang
Cong Liu
David Leibly
Meytal Landau
Minglei Zhao
Michael P Hughes
David S Eisenberg
author_sort Lin Jiang
collection DOAJ
description Amyloid protein aggregates are associated with dozens of devastating diseases including Alzheimer’s, Parkinson’s, ALS, and diabetes type 2. While structure-based discovery of compounds has been effective in combating numerous infectious and metabolic diseases, ignorance of amyloid structure has hindered similar approaches to amyloid disease. Here we show that knowledge of the atomic structure of one of the adhesive, steric-zipper segments of the amyloid-beta (Aβ) protein of Alzheimer’s disease, when coupled with computational methods, identifies eight diverse but mainly flat compounds and three compound derivatives that reduce Aβ cytotoxicity against mammalian cells by up to 90%. Although these compounds bind to Aβ fibers, they do not reduce fiber formation of Aβ. Structure-activity relationship studies of the fiber-binding compounds and their derivatives suggest that compound binding increases fiber stability and decreases fiber toxicity, perhaps by shifting the equilibrium of Aβ from oligomers to fibers.
first_indexed 2024-04-12T02:17:56Z
format Article
id doaj.art-5a7cefc5de85489599727b82100f59f6
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T02:17:56Z
publishDate 2013-07-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-5a7cefc5de85489599727b82100f59f62022-12-22T03:52:12ZengeLife Sciences Publications LtdeLife2050-084X2013-07-01210.7554/eLife.00857Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid betaLin Jiang0Cong Liu1David Leibly2Meytal Landau3Minglei Zhao4Michael P Hughes5David S Eisenberg6Departments of Chemistry and Biochemistry and Biological Chemistry, Howard Hughes Medical Institute, UCLA–DOE Institute for Genomics and Proteomics, University of California, Los Angeles, Los Angeles, United StatesDepartments of Chemistry and Biochemistry and Biological Chemistry, Howard Hughes Medical Institute, UCLA–DOE Institute for Genomics and Proteomics, University of California, Los Angeles, Los Angeles, United StatesDepartments of Chemistry and Biochemistry and Biological Chemistry, Howard Hughes Medical Institute, UCLA–DOE Institute for Genomics and Proteomics, University of California, Los Angeles, Los Angeles, United StatesDepartments of Chemistry and Biochemistry and Biological Chemistry, Howard Hughes Medical Institute, UCLA–DOE Institute for Genomics and Proteomics, University of California, Los Angeles, Los Angeles, United StatesDepartments of Chemistry and Biochemistry and Biological Chemistry, Howard Hughes Medical Institute, UCLA–DOE Institute for Genomics and Proteomics, University of California, Los Angeles, Los Angeles, United StatesDepartments of Chemistry and Biochemistry and Biological Chemistry, Howard Hughes Medical Institute, UCLA–DOE Institute for Genomics and Proteomics, University of California, Los Angeles, Los Angeles, United StatesDepartments of Chemistry and Biochemistry and Biological Chemistry, Howard Hughes Medical Institute, UCLA–DOE Institute for Genomics and Proteomics, University of California, Los Angeles, Los Angeles, United StatesAmyloid protein aggregates are associated with dozens of devastating diseases including Alzheimer’s, Parkinson’s, ALS, and diabetes type 2. While structure-based discovery of compounds has been effective in combating numerous infectious and metabolic diseases, ignorance of amyloid structure has hindered similar approaches to amyloid disease. Here we show that knowledge of the atomic structure of one of the adhesive, steric-zipper segments of the amyloid-beta (Aβ) protein of Alzheimer’s disease, when coupled with computational methods, identifies eight diverse but mainly flat compounds and three compound derivatives that reduce Aβ cytotoxicity against mammalian cells by up to 90%. Although these compounds bind to Aβ fibers, they do not reduce fiber formation of Aβ. Structure-activity relationship studies of the fiber-binding compounds and their derivatives suggest that compound binding increases fiber stability and decreases fiber toxicity, perhaps by shifting the equilibrium of Aβ from oligomers to fibers.https://elifesciences.org/articles/00857amyloid fibercomputational biologydrug discoveryAlzheimer's diseaseligand docking
spellingShingle Lin Jiang
Cong Liu
David Leibly
Meytal Landau
Minglei Zhao
Michael P Hughes
David S Eisenberg
Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta
eLife
amyloid fiber
computational biology
drug discovery
Alzheimer's disease
ligand docking
title Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta
title_full Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta
title_fullStr Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta
title_full_unstemmed Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta
title_short Structure-based discovery of fiber-binding compounds that reduce the cytotoxicity of amyloid beta
title_sort structure based discovery of fiber binding compounds that reduce the cytotoxicity of amyloid beta
topic amyloid fiber
computational biology
drug discovery
Alzheimer's disease
ligand docking
url https://elifesciences.org/articles/00857
work_keys_str_mv AT linjiang structurebaseddiscoveryoffiberbindingcompoundsthatreducethecytotoxicityofamyloidbeta
AT congliu structurebaseddiscoveryoffiberbindingcompoundsthatreducethecytotoxicityofamyloidbeta
AT davidleibly structurebaseddiscoveryoffiberbindingcompoundsthatreducethecytotoxicityofamyloidbeta
AT meytallandau structurebaseddiscoveryoffiberbindingcompoundsthatreducethecytotoxicityofamyloidbeta
AT mingleizhao structurebaseddiscoveryoffiberbindingcompoundsthatreducethecytotoxicityofamyloidbeta
AT michaelphughes structurebaseddiscoveryoffiberbindingcompoundsthatreducethecytotoxicityofamyloidbeta
AT davidseisenberg structurebaseddiscoveryoffiberbindingcompoundsthatreducethecytotoxicityofamyloidbeta